Perrigo misses on adjusted profit


For the first time in five consecutive quarters, Perrigo has missed adjust profit estimates. The drug maker’s branded business has disappointed, and the company’s shares fell as much as 10 percent.

Read the source article at

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>